《以病毒和细胞为靶点抑制HIV-1复制的RNA干扰技术》

  • 来源专题:艾滋病防治
  • 编译者: 李越
  • 发布时间:2005-04-17
  • Human immunodeficiency virus type 1 (HIV-1) gene expression is regulated by both cellular transcription factors and Tat. The ability of Tat to stimulate transcriptional elongation is dependent on its binding to TAR RNA in conjunction with cyclin T1 and CDK9. A variety of other cellular factors that bind to the HIV-1 long terminal repeat, including NF-κB, SP1, LBP, and LEF, are also important in the control of HIV-1 gene expression. Although these factors have been demonstrated to regulate HIV-1 gene expression by both genetic and biochemical analysis, in most cases a direct in vivo demonstration of their role on HIV-1 replication has not been established. Recently, the efficacy of RNA interference in mammalian cells has been shown utilizing small interfering RNAs (siRNAs) to result in the specific degradation of host mRNAs and decreases the levels of their corresponding proteins. In this study, we addressed whether siRNAs directed against either HIV-1 tat or reverse transcriptase or the NF-κB p65 subunit could specifically decrease the levels of these proteins and thus alter HIV-1 replication. Our results demonstrate the specificity of siRNAs for decreasing the expression of these viral and cellular proteins and inhibiting HIV-1 replication. These studies suggest that RNA interference is useful in exploring the biological role of cellular and viral regulatory factors involved in the control of HIV-1 gene expression
  • 原文来源:http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=136685
相关报告
  • 《铁硫簇—抑制新冠病毒复制的新靶点》

    • 来源专题:新药创制
    • 编译者:杜慧
    • 发布时间:2021-06-23
    • 美国国家癌症研究所的研究人员发表于Science上,题为“Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets”的论文称,新冠病毒RNA聚合酶催化亚基存在铁硫簇,对于病毒的复制至关重要,利用氧化剂破坏铁硫簇能够有效抑制病毒。 SARS-CoV-2 依赖于RNA聚合酶(RdRp)基因复制和转录,研究人员发现 RdRp 的催化亚基 nsp12 在模拟为锌中心的位点连接两个铁硫金属辅助因子,而这些金属结合位点对于复制和与病毒解旋酶的相互作用是必不可少的。研究人员在细胞模型上测试了TEMPOL,发现该化合物既能够抑制RdRP,又能够与瑞德西韦协同发挥作用。因此,这些铁硫簇可作为 SARS-CoV-2 RdRp 的辅助因子,并且是 COVID-19 治疗靶点。
  • 《CRISPR / Cas9诱导突变可抑制HIV-1复制并加速病毒逃脱》

    • 来源专题:艾滋病防治
    • 编译者:门佩璇
    • 发布时间:2016-04-15
    • CRISPR/Cas9(Clustered Regularly Interspaced Short Palindromic Repeats)是最新出现的一种由RNA指导的Cas9核酸酶对靶向基因进行编辑的技术。日前,来自犹太综合医院等机构的研究者联合开展研究,通过利用CRISPR/Cas9在细胞DNA中突变HIV-1,研究人员发现,Cas9/sgRNA能够抑制HIV-1的复制,HIV-1能够逃脱由Cas9/sgRNA诱导的抑制。研究还发现,逃脱突变位点位于目标病毒DNA的Cas9裂解位点上,Cas9/sgRNA诱导的突变又能够协助病毒逃脱。当单一突变可以抑制病毒复制时,其中有些突变还会促进病毒产生耐药性。可见,靶向作用多个病毒DNA区域对于开发有效的CRISPR/Cas9抗病毒疗法显得非常必要。